In the Democratic Republic of the Congo, a clinical trial of an experimental treatment for the Bundibugyo strain of the Ebola virus has started amid an outbreak that has already claimed over 500 lives. This is reported by Bloomberg, writes UNN.
Details
As part of the study coordinated by the World Health Organization, patients receive a cocktail of monoclonal antibodies MBP134, the antiviral drug remdesivir, and optimized supportive therapy. The trial is being conducted in the Ituri province, where the highest number of cases has been recorded.
The outbreak is the largest for this Ebola strain
According to the WHO, the study has an adaptive format that will allow it to continue during future outbreaks if the current epidemic ends before sufficient results are obtained.
This gives real hope that we can achieve concrete results for the communities at the center of the outbreak
The current outbreak has already affected nearly 1,600 people in the Democratic Republic of the Congo and neighboring Uganda, becoming the largest in history for the Bundibugyo strain. Currently, there are no approved vaccines or specific treatments for this particular variant of the virus.
Confirmed Ebola outbreak cases in Congo exceed 1,000, 254 people dead22.06.26, 16:53
Adults, children, pregnant women, and breastfeeding mothers can participate in the study. At the same time, medics continue to work in a difficult security situation: attacks on response teams and cases of damage to infrastructure related to the fight against Ebola are being recorded in the outbreak areas.
Trump asks Congress for over $1.4 billion to fight the Ebola outbreak25.06.26, 02:57